The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $136.23

Today's change+2.19 +1.63%
Updated December 17 2:40 PM EST. Delayed by at least 15 minutes.
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $136.23

Today's change+2.19 +1.63%
Updated December 17 2:40 PM EST. Delayed by at least 15 minutes.

Becton Dickinson and Co up sharply

Becton Dickinson and Co is up sharply today, rallying (U.S.)$2.19 or 1.63% to (U.S.)$136.23. Shares have lost 0.31% over the last five days, but sit 4.44% below their 52-week high. This security has outperformed the S&P 500 by 16.24% during the last year.

Key company metrics

  • Open(U.S.) $135.05
  • Previous close(U.S.) $134.04
  • High(U.S.) $136.86
  • Low(U.S.) $134.48
  • Bid / Ask(U.S.) $136.17 / (U.S.) $136.24
  • YTD % change+23.30%
  • Volume1,135,770
  • Average volume (10-day)1,193,796
  • Average volume (1-month)1,245,731
  • Average volume (3-month)1,603,053
  • 52-week range(U.S.) $105.21 to (U.S.) $142.56
  • Beta0.88
  • Trailing P/E22.70×
  • P/E 1 year forward19.70×
  • Forward PEG2.73×
  • Indicated annual dividend(U.S.) $2.40
  • Dividend yield1.76%
  • Trailing EPS(U.S.) $6.00
Updated December 17 2:40 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.03%

Based on its net profit margin of 14.03%, Becton Dickinson and Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.24%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue2,2022,1572,0722,014
Total other revenue--------
Total revenue2,2022,1572,0722,014
Gross profit1,1021,1111,0531,034
Total cost of revenue1,1001,0461,019980
Total operating expense1,8011,7121,6911,636
Selling / general / administrative561528525531
Research & development140137147126
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--10-1
Operating income401445381378
Interest income (expense), net non-operating-36-33-33-34
Gain (loss) on sale of assets--------
Other--------
Income before tax377423363359
Income after tax301326287271
Income tax, total76977688
Net income301326287271
Total adjustments to net income--------
Net income before extra. items301326287271
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items301326287271
Inc. avail. to common incl. extra. items301326287271
Diluted net income301326287271
Dilution adjustment--------
Diluted weighted average shares197197197198
Diluted EPS excluding extraordinary itemsvalue per share1.521.651.451.37
Dividends per sharevalue per share0.550.550.550.54
Diluted normalized EPSvalue per share1.521.651.451.37